Amarin Corporation PLC Stock News

Amarin (AMRN) closed at $6.78 in the latest trading session, marking a +0.89% move from the prior day.

The World Health Organisation (WHO) says it is stopping hydroxychloroquine solidarity trial for the treatment of COVID-19 patients. This comes three days after the United States Food and Drug Admini

The FDA has identified four manufacturers labeled as homeopaths that are distributing dangerous injectable drugs.

Amarin (AMRN) is seriously undervalued, according to Cantor analyst Louise Chen.On Monday, the drug maker presented encouraging new data from the REDUCE-IT study. After taking 4g a day of Vascepa, Ama

Our mission is to save the 45,000 African Americans lives lost each year from tobacco-induced diseases and we have resolutely

Amarin Corporation plc (NASDAQ: AMRN) announced late Tuesday a settlement agreement with Apotex for resolving a patent lawsuit regarding a generic version of Amarin's drug Vascepa. The Amarin Analysts

Here's a roundup of top developments in the biotech space over the last 24 hour.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) * ADC Therapeutics SA (NYSE: ADCT) * Adverum Biotechn

Amarin (AMRN) has announced a settlement agreement with Apotex Inc. that resolves a patent litigation over Apotex’s abbreviated new drug application (ANDA) seeking US approval of a generic form of V

Amarin Corporation plc (NASDAQ: AMRN) announced late Tuesday a settlement agreement with Apotex for resolving a patent lawsuit regarding a generic version of Amarin's drug...

DUBLIN, Ireland and BRIDGEWATER, N.J., June 16, 2020 -- Amarin Corporation plc (NASDAQ:AMRN) announced today a settlement agreement with Apotex Inc. (Apotex) that resolves.

June 16th, 2020. Good evening. Brazilian National Treasury secretary, Mansueto Almeida, has decided to resign from government within the next few weeks. Almeida, who had occupied the position sinc

The United States Food and Drug Administration will revoke its emergency authorisation of anti-malaria drug hydroxychloroquine after finding it ineffective in treating COVID-19. The FDA said "in light

The United States Food and Drug Administration on Monday withdrew the emergency use authorization it granted for hydroxychloroquine and chloroquine sulfates against the COVID-19...

The United States Foo stration (FDA) says it is withdrawing its approval for the emergency use of two anti-malaria drugs the treatment of COVID-19